Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Johnson & Johnson is discontinuing its phase 2 field study on the efficacy of a candidate drug for dengue, according to a company press release. The study was designed to evaluate the efficacy of an investigational drug known as mosnodenvir…